Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

Bjorn Gudbjornsson1 Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland;2 Faculty of Medicine, University of Iceland, Reykjavik, IcelandCorrespondence[email protected]

Arni Jon Geirsson3 Department of Rheumatology, University Hospital, Reykjavik, Iceland;4 Laeknasetrid - Medical Clinic, University of Iceland, Reykjavik, Iceland

Niels Steen Krogh5 Zitelab Aps, Copenhagen, Denmark

Pages 13-19 | Published online: 04 May 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

LoveTJGudbjornssonBGudjonssonJEValdimarssonHPsoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease courseJ Rheumatol200734102082208817696270
PubMed Web of Science ®Google Scholar
GossecLSmolenJSGaujoux-VialaCEuropean League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapiesAnn Rheum Dis201271141221953336
PubMed Web of Science ®Google Scholar
CoatesLCKavanaughAMeasePJGroup for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisArthritis Rheumatol20166851060107126749174
PubMed Web of Science ®Google Scholar
Icelandic guideline for using boDMARDs in PsA Available from https://www.landspitali.is/fagfolk/kliniskar-leidbeiningar/leit-i-klinis-kum-leidbeiningum/Accessed April 23, 2018
Google Scholar
AntoniCEKavanaughAKirkhamBSustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Arthritis Rheum20055241227123615818699
PubMed Web of Science ®Google Scholar
AntoniCKruegerGGde VlamKInfliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trialAnn Rheum Dis20056481150115715677701
PubMed Web of Science ®Google Scholar
GottliebABEvansRLiSInfliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trialJ Am Acad Dermatol200451453454215389187
PubMed Web of Science ®Google Scholar
CauzaESpakMCauzaKTreatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximabRheumatol Int200222622723212426660
PubMed Web of Science ®Google Scholar
Di RenzoLSaracenoRSchipaniCChimentiSDe LorenzoAWhy 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis?J Dermatol2009361266666819958455
PubMed Web of Science ®Google Scholar
TengaGGoebVLequerreTA 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costsJoint Bone Spine2011781505520646950
PubMed Web of Science ®Google Scholar
GlintborgBGudbjornssonBKroghNSImpact of different inf-liximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIORheumatology (Oxford)201453112100210924939677
PubMed Web of Science ®Google Scholar
JoisRNLeederJGibbALow-dose infliximab treatment for ankylosing spondylitis–clinically- and cost-effectiveRheumatology (Oxford)200645121566156916705043
PubMed Web of Science ®Google Scholar
YatesMKeatAGaffneyKDo low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?Rheumatology (Oxford)201655576977226660639
PubMed Web of Science ®Google Scholar
DANBIO [database on the Internet]Danish Rheumatological DatabaseGlostrup: Denmark Available from: https://danbio-online.dkAccessed April 3, 2018
Google Scholar
KristensenLEGulfeASaxneTGeborekPEfficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group registerAnn Rheum Dis200867336436917644547
PubMed Web of Science ®Google Scholar
CarrascosaJMRocamoraVFernandez-TorresRMObesity and psoriasis: Inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implicationsActas Dermosifiliogr20141051314423177976
PubMedGoogle Scholar
StrohalRKirbyBPuigLPsoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisJ Eur Acad Dermatol Venereol201428121661166924372845
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date